 Shares of 3M Co. MMM, -1.04% slid 1.5% in morning trading Wednesday, enough to pace the Dow Jones
 Average’s DJIA, +0.11% decliners, after S&P Global Ratings downgraded the the consumer, industrial
 health care-products company’s credit following the company’s agreement to pay up to $6 billion to
 litigation over its Combat Arms earplugs. S&P cut 3M’s credit to a BBB+ rating, which leaves it
 three notches above speculative grade, or “junk”, territory. The rating outlook remains negative.
 said that while the settlement is “very reasonable” and provides a “degree of clarity,” it
 adjusted debt by about $4 billion. Meanwhile, Moody’s Investors Service said that while the Combat
 settlement was “credit negative,” the terms were “less onerous” than expected and reduce
 As a result, Moody’s kept 3M’s credit rating at A2, which is five notches above junk status, but
 the outlook at negative. The stock had gained 1.4% on Tuesday following the Combat Arms settlement
 after surging 5.2% on Monday amid reports that a settlement was coming. The stock has shed 13.3%
 to date while the Dow has tacked on 5.2%. Salesforce Inc. co-founder and Chief Executive Marc
 warned Tuesday that the company's upcoming Dreamforce conference could be its last in San Francisco
 it's affected by the city's homelessness and open drug use. Tomi Kilgore is MarketWatch's deputy
 and corporate news editor and is based in New York. You can follow him on Twitter @TomiKilgore.Tomi
 is MarketWatch's deputy investing and corporate news editor and is based in New York. You can
 him on Twitter @TomiKilgore.Intraday Data provided by FACTSET and subject to terms of use.
 and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time
 sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed
